IgG-NMO status after vitamin D supplementation in patients with NMOSD: a case report and a review of literature
Keywords:
Neuromyelitisoptica Spectrum Disorder, vitamin D, supplement, Immunoglobulin GAbstract
Introduction: Neuromyelitis optica Spectrum Disorder (NMOSD) is an inflammatory disorder of the CNS that presents typically with relapses of optic neuritis or transverse myelitis, in which IgG autoantibodies against aquaporin-4 water channel protein probably play a pathogenic role. We presented two cases who newly diagnosed with NMOSD that presented alterations in IgG-NMO status after vitamin D supplementation. Case presentation: We reported 2 cases, a 36-year-old female and a 27-year-old male newly diagnosed with NMOSD. Cases were stable in remission and experienced no attack and none of them didn’t take pulse therapy in the previous 3 months. Vitamin D level and IgG-NMO titration in 36-year-old female were 21 ng/dl and 1/320, and in 27-years-old male were 29 ng/dl 1/100, respectively. As their prescription, they took 50000 IU of vitamin D3 per week for 15 weeks. After 15 weeks vitamin D level raised in both of them and IgG-NMO titration was negative in cases. Conclusion: We reported 2 cases with high titration of IgG-NMO whom IgG-NMO status altered after high dose of vitamin D supplementation. Physiological variation in vitamin D may apply a major impact on autoimmune and inflammatory diseases. Further studies with larger sample sizes need to prove these results.
Downloads
Published
Issue
Section
License
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.